Clinical Trial Detail

NCT ID NCT03004287
Title 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Arkansas
Indications

multiple myeloma

Therapies

Melphalan

Carfilzomib

Cisplatin

Cyclophosphamide

Lenalidomide

Dexamethasone

Daratumumab

Bortezomib

Etoposide

Doxorubicin

Thalidomide

Age Groups: adult senior

No variant requirements are available.